Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06034509 · ClinicalTrials.gov registry record

Cognitive and Vascular Functioning Following TBI

A clinical trial of Traumatic Brain Injury and Cognitive Decline, sponsored by Walter Reed National Military Medical Center.

Recruiting
Registry status
300
Enrollment target
1
Study location

NCT06034509 is a study of Traumatic Brain Injury and Cognitive Decline that is actively recruiting participants, run by Walter Reed National Military Medical Center. The registered enrollment target is 300 participants, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06034509, a study of Traumatic Brain Injury and Cognitive Decline, is actively recruiting participants, sponsored by Walter Reed National Military Medical Center.

RECRUITING
Registry status
300 participants
Enrollment target
1
Study location

Study Summary

This observational study will examine the association of chronic traumatic cerebrovascular injury and cardiovascular risk factors with TBI-related cognitive impairment and vascular dementia. Cerebrovascular, inflammatory, and neurodegenerative blood biomarkers as well as clinical and neuroimaging data

Interventions

  • OTHER No intervention. This is an observational study.

Study Locations (1)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-11-27
Est. Completion 2027-05

What the Registry Record Tells You About NCT06034509

The ClinicalTrials.gov registry entry for NCT06034509 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 276-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target. The listed sponsor is Walter Reed National Military Medical Center, which has 48 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Traumatic Brain Injury appearing as the primary indexed condition, and to 1 intervention - of which No intervention. This is an observational study. is the first listed.

NCT06034509 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06034509 about?

NCT06034509 is a clinical study titled "Cognitive and Vascular Functioning Following TBI". This observational study will examine the association of chronic traumatic cerebrovascular injury and cardiovascular risk factors with TBI-related cognitive impairment and vascular dementia. Cerebrovascular, inflammatory, and neurodegenerative blood biomarkers as well as clinical and neuroimaging da...

What is the current status of trial NCT06034509?

This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-11-27. Estimated completion is 2027-05.

What conditions does trial NCT06034509 study?

This clinical trial studies the following conditions: Traumatic Brain Injury, Cognitive Decline, Vascular Dementia.

What interventions are being tested in trial NCT06034509?

The interventions under investigation include: No intervention. This is an observational study. (OTHER).

Who is sponsoring clinical trial NCT06034509?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06034509 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.